S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Clinical trial NCT01693419 · COMPLETED

Trial details

NCT number: NCT01693419
Sponsor: Hallym University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Neoplasms

Start date: 2011-08-01
Primary completion: 2016-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.